References
- Schwartz RH: Urine testing in. the detection of drugs of abuse. Archives of Internal Medicine, 148(11):2407–2412, 1988
- Finkle BS: Drug-analysis technology: Overview and state of the art. Clinical Chemistry, 33(11 Suppl): 13B-17B, 1987
- Tennant F, Shannon J: Quantitative urine testing: A new tool for diagnosing and treating cocaine use. Post-graduate Medicine, 86(3): 107–114, 1989
- Saxon AJ, Calsyn DA, Harver VM, Delaney CJ: Clin-ical evaluation and use of urine screening for drug abuse. Western J Medicine 149(3): 296–303, 1988
- Cone EJ, Weddington WW Jr: Prolonged occurrence of cocaine in human saliva and urine after chronic use. J Analytical Toxicology 13: 65–68, 1989
- Poklis A: Evaluation of TDX cocaine metabolite assay. J Analytical Toxicology, 11(5): 228–230, 1987
- Cone ET, Menchen SL, Mitchell J: Validity testing of the TDx cocaine metabolite assay with human speci-mens obtained after intravenous cocaine administra-tion. Forensic Science Int 37: 265–275, 1988
- Barnett G, Hawks R, Resnick R: Cocaine pharmacoki-netics in humans. J Ethnopharmacology 3: 353–366, 1981
- Chow MJ, Ambre JJ, Ruo TI, Atkinson AJ, Bowsher DJ, Fischman MW: Kinetics of cocaine distribution, elimination, and chronotropic effects. Clin Pharmacol Ther 38: 318–324, 1985
- Javaid JI, Musa MN, Fischman CR, Schuster CR, Davis JM: Kinetics of cocaine in humans after intravenous and intranasal administration. Clin Pharmacol Ther 4: 9–18, 1983
- Wilkinson P, Van Dyke P. Jatlow P. Barash P. Byck R: Intranasal and oral cocaine kinetics. Clin Pharmacol Ther 27: 386–394, 1980
- Ambre J: The urinary excretion of cocaine and metab-olites in humans: A kinetic analysis of published data. J Analytic Toxicol 9: 241–245, 1985
- Jatlow P: Drug of abuse profile: Cocaine. Clin Chem 33: 66B-72B, 1987
- Weiss RD, Gawin FH: Protracted eliminations of co-caine metabolites in long-term high-dose cocaine abusers. Am J Med 85(6): 879–880, 1988
- Halikas JA, Crosby RD, Carlson GA, Crea F, Graves NM, Bowers LD: Cocaine reduction in unmotivated crack users using carbamazepine versus placebo in a short term crossover design. J Clin Pharmacol Ther-apeutics, 1991, in press.